WorldStage Newsonline– May & Baker Nigeria Plc which is involved in the manufacture, sale and distribution of human pharmaceuticals, human vaccines and consumer products has released its unaudited consolidated statement of profit or loss and other comprehensive income for the year ended 31 December, 2021with 42% decline in profit for the fourth quarter to N96.922 million from N167.130 million in Q4 2020.
However, profit margin for the full year was stronger with only 4.31% drop to N979.355 million from N964.564 million in 2020.
.Revenue for the Q4 rose to N3.837 billion from N2.952 billion in 2020 while the figure for the full year rose to N11902 billion from N9.390 billion in 2020.
